Latest News

SARS-CoV-2 may confound seasons, persist in warmer months, report shows


 

Worrisome Persistence on Masks

Seasonality can also be potentially gauged in the laboratory. Most of the studies on environmental persistence of SARS-CoV-2 have been conducted using virus grown in tissue culture. But that, too, is an imperfect method.

Virus disseminated into the environment from naturally infected humans likely has different survival properties than virus grown in culture, said Relman.

In addition, many labs cannot, or fail to, control and vary relative humidity, the committee letter noted. The aerosol studies so far have used humidity levels of 50% to 65%, which is more favorable to decay, while respiratory fluid is more likely to protect against infectivity, and the 20%-to-40% wintertime indoor humidity in temperate regions is more favorable for virus survival.

Even with these caveats, the committee cited worrisome studies on SARS-CoV-2 survival.

In a study published April 2 online in The Lancet, Hong Kong researchers reported significant reductions in virus in culture starting with temperatures at 37°C (98.6°F) or above.

On surfaces at a room temperature of 22°C (71.6°F) with a relative humidity of 65%, there was no infectious virus on printing paper or tissue papers after just 3 hours. It took 4 days for an infectious level to break down on glass and money, and 7 days for stainless steel and plastic. But after 7 days, investigators found 0.1% of the original inoculum on the outside of a surgical mask.

“The persistence of infectious virus on PPE is concerning,” writes Relman, noting that more studies are needed to guide healthcare workers, especially on what might be used to disinfect personal protective equipment “when they cannot be discarded after single use.”

Chad Roy, PhD, a researcher from Tulane University National Primate Research Center in New Orleans, Louisiana, told Relman by phone that in experiments where the virus was suspended as an aerosol at a temperature of 23°C (73.4° F) and about 50% humidity, SARS-CoV-2 had a longer half-life than the influenza virus, SARS-CoV-1, monkeypox virus, and Mycobacterium tuberculosis.

“This result is also concerning, but quite preliminary,” writes Relman.

This article first appeared on Medscape.com.

Pages

Recommended Reading

Coronavirus tests are being fast-tracked by the FDA, but it’s unclear how accurate they are
Journal of Clinical Outcomes Management
Doing things right vs. doing the right things
Journal of Clinical Outcomes Management
NYC hospitals require health care workers to report in person, even for phone and telehealth work
Journal of Clinical Outcomes Management
COVID-19 hits physician couple: Dramatically different responses
Journal of Clinical Outcomes Management
Presymptomatic or asymptomatic? ID experts on shifting terminology
Journal of Clinical Outcomes Management
ASCO announces its own COVID-19 and cancer registry
Journal of Clinical Outcomes Management
ABIM grants MOC extension
Journal of Clinical Outcomes Management
Remdesivir tops list of promising COVID-19 treatments in review of nearly 300 trials
Journal of Clinical Outcomes Management
What do early remdesivir data suggest?
Journal of Clinical Outcomes Management
CMS loosens clinician scope-of-practice, telehealth rules for COVID-19 crisis
Journal of Clinical Outcomes Management